Mutations Preventing the Phosphorylation of Human Ribosomal Protein uS15 at Y38 and S48 Reduce the Efficiency of its Transfer into the Nucleolus


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The ribosomal protein uS15 is one of the key proteins forming the small (40S) ribosomal subunit structure around the central domain of 18S rRNA. According to a number of proteomic studies based on mass-spectrometry analysis, there are many phosphorylation sites in this protein. However, when the protein uS15 is contained in the 40S subunit, it does not carry such posttranslational modification. In this study, it was found that the cytoplasmic protein kinases of HEK293T cells are able to phosphorylate the human recombinant ribosomal protein uS15 with significantly greater efficiency than that of the nucleus protein kinases. The effect of the amino acid substitutions Y38A and S48A preventing the phosphorylation of the ribosomal protein uS15 at the corresponding sites, on the transport of the recombinant protein uS15 fused to the green fluorescent protein in the nucleolus was studied. It was shown that single mutations at the above sites have little effect on the transport of this protein, whereas double mutation reduces the efficiency of this process by more than a quarter. The findings suggest the importance of phosphorylation of the ribosomal protein uS15 by cytoplasmic protein kinases at several sites, including Y38A and S48A, for its efficient transfer into the nucleolus, where pre-ribosomal subunits are assembled.

About the authors

A. E. Vasilyeva

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Science; Novosibirsk State University

Email: malygin@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk

D. D. Yanshina

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Science

Email: malygin@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090

G. G. Karpova

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Science; Novosibirsk State University

Email: malygin@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk

A. A. Malygin

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Science; Novosibirsk State University

Author for correspondence.
Email: malygin@niboch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk


Copyright (c) 2019 Pleiades Publishing, Ltd.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies